Transcriptomics

Dataset Information

0

Ixekizumab treatment of patients with moderate-to-severe plaque psoriasis.


ABSTRACT: Objectives: To asses skin clearance and patient-reported outcomes for ixekizumab treatment. Methods: IXORA-R enrolled adults with moderate-to-severe plaque psoriasis, defined as static Physician’s Global Assessment ≥ 3, PASI ≥ 12 and involved body surface area ≥ 10%. The trial was registered with ClinicalTrials.gov (NCT03573323).

ORGANISM(S): Homo sapiens

PROVIDER: GSE178228 | GEO | 2023/04/10

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

| PRJNA737931 | ENA
2017-01-27 | GSE83582 | GEO
2024-02-26 | GSE256275 | GEO
| S-EPMC7475056 | biostudies-literature
2020-05-28 | GSE151278 | GEO
| S-EPMC8599386 | biostudies-literature
2022-03-19 | GSE198805 | GEO
2015-06-30 | E-MTAB-4015 | biostudies-arrayexpress
2024-07-31 | GSE252029 | GEO
2021-01-20 | GSE165149 | GEO